Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenes Strains
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (3) , 596-600
Abstract
Resistance to expanded-spectrum cephalosporins commonly develops in Enterobacter aerogenes during therapy due to selection of mutants producing high levels of the chromosomal Bush group 1 β-lactamase. Recently, resistant strains producing plasmid-mediated extended-spectrum β-lactamases (ESBLs) have been isolated as well. A study was designed to investigate ESBL production among 31 clinical isolates of E. aerogenes from Richmond, Va., with decreased susceptibility to expanded-spectrum cephalosporins and a positive double-disk potentiation test. Antibiotic susceptibility was determined by standard disk diffusion and agar dilution procedures. β-Lactamases were investigated by an isoelectric focusing overlay technique which simultaneously determined isoelectric points (pIs) and substrate or inhibitor profiles. Decreased susceptibility to cefotaxime, ceftazidime, and aztreonam (MIC range, 1 to 64 μg/ml) was detected and associated with resistance to gentamicin and trimethoprim-sulfamethoxazole. All strains produced an inducible Bush group 1 β-lactamase (pI 8.3). Twenty-nine of the 31 isolates also produced an enzyme similar to SHV-4 (pI 7.8), while 1 isolate each produced an enzyme similar to SHV-3 (pI 6.9) and to SHV-5 (pI 8.2). The three different SHV-derived ESBLs were transferred by transconjugation to Escherichia coli C600N and amplified by PCR. Plasmid profiles of the clinical isolates showed a variety of different large plasmids. Because of the linkage of resistance to aminoglycosides and trimethoprim-sulfamethoxazole with ESBL production, it is possible that the usage of these drugs was responsible for selecting plasmid-mediated resistance to extended-spectrum cephalosporins in E. aerogenes . Furthermore, it is important that strains such as these be recognized, because they can be responsible for institutional spread of resistance genes.Keywords
This publication has 28 references indexed in Scilit:
- SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patientsAntimicrobial Agents and Chemotherapy, 1995
- The antimicrobial activity of cefotaxime: Comparative multinational hospital isolate surveys covering 15 yearsInfection, 1994
- Resistance characteristics of blood culture isolates of Enterobacter cloacae with special reference to beta‐lactamases and relation to preceding antimicrobial therapyAPMIS, 1994
- Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitalsJournal of Antimicrobial Chemotherapy, 1993
- Relationship between ceftriaxone use and resistance of Enterobacter speciesJournal of Clinical Pharmacy and Therapeutics, 1992
- -Lactamases of Gram-Negative Bacteria: New Challenges for New DrugsClinical Infectious Diseases, 1992
- Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospitalJournal of Antimicrobial Chemotherapy, 1991
- Enterobacter Bacteremia in Pediatric PatientsClinical Infectious Diseases, 1990
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975